Lisa Pickering

15.7k total citations
74 papers, 1.2k citations indexed

About

Lisa Pickering is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Lisa Pickering has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Lisa Pickering's work include Renal cell carcinoma treatment (37 papers), Renal and related cancers (23 papers) and Cancer Genomics and Diagnostics (21 papers). Lisa Pickering is often cited by papers focused on Renal cell carcinoma treatment (37 papers), Renal and related cancers (23 papers) and Cancer Genomics and Diagnostics (21 papers). Lisa Pickering collaborates with scholars based in United Kingdom, United States and Canada. Lisa Pickering's co-authors include James Larkin, Charles Swanton, Martin Gore, Robert J. Jones, Walter M. Stadler, Andrew Protheroe, Theodore F. Logan, Igor Puzanov, Christian Kollmannsberger and Susan Halabi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lisa Pickering

68 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Pickering United Kingdom 17 705 603 384 378 234 74 1.2k
Lionnel Geoffrois France 21 844 1.2× 504 0.8× 268 0.7× 595 1.6× 675 2.9× 90 1.6k
Jinsoo Chung South Korea 23 979 1.4× 493 0.8× 325 0.8× 449 1.2× 634 2.7× 143 1.7k
Albiruni Ryan Abdul Razak Canada 18 375 0.5× 410 0.7× 185 0.5× 661 1.7× 257 1.1× 100 1.3k
Teodoro Sava Italy 18 554 0.8× 292 0.5× 231 0.6× 502 1.3× 282 1.2× 69 1.1k
Stephen B. Riggs United States 17 989 1.4× 674 1.1× 350 0.9× 324 0.9× 408 1.7× 50 1.4k
Nancy B. Davis United States 16 372 0.5× 297 0.5× 175 0.5× 472 1.2× 220 0.9× 61 989
Enrique Gallardo Spain 18 621 0.9× 500 0.8× 315 0.8× 480 1.3× 571 2.4× 90 1.6k
Philippe Barthélémy France 20 752 1.1× 481 0.8× 276 0.7× 765 2.0× 599 2.6× 123 1.6k
Andrew Dean Australia 17 694 1.0× 262 0.4× 267 0.7× 1.1k 2.9× 198 0.8× 104 1.6k
Cristian Lolli Italy 19 761 1.1× 274 0.5× 331 0.9× 578 1.5× 263 1.1× 88 1.4k

Countries citing papers authored by Lisa Pickering

Since Specialization
Citations

This map shows the geographic impact of Lisa Pickering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Pickering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Pickering more than expected).

Fields of papers citing papers by Lisa Pickering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Pickering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Pickering. The network helps show where Lisa Pickering may publish in the future.

Co-authorship network of co-authors of Lisa Pickering

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Pickering. A scholar is included among the top collaborators of Lisa Pickering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Pickering. Lisa Pickering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grünwald, Viktor, Axel Bex, Sylvie Rottey, et al.. (2025). Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study. European Journal of Cancer. 225. 115569–115569. 1 indexed citations
2.
McCarthy, Elizabeth, Amy L. Chadwick, J.J. Soto Castillo, et al.. (2025). A multi-centre review of the use of adjuvant pembrolizumab for renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 484–484.
3.
Rush, Hannah, Alison Fielding, Lisa Pickering, et al.. (2024). Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition. British Journal of Cancer. 131(3). 515–523. 2 indexed citations
4.
Serra-Bellver, Patricio, Judith M. Versluis, Cong Zhou, et al.. (2022). Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study. European Journal of Cancer. 176. 121–132. 14 indexed citations
5.
Alexander, James L., Hajir Ibraheim, Benjamin Shum, et al.. (2022). Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis. Journal for ImmunoTherapy of Cancer. 10(9). e005490–e005490. 6 indexed citations
6.
Young, Kate, Andreas M. Schmitt, Deborah Mukherji, et al.. (2022). Management of Toxicity and Side Effects of Systemic Therapy for Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 3(6). 484–498.
7.
Armstrong, Andrew J., Andrew B. Nixon, Qian Yang, et al.. (2021). Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 27(12). 3317–3328. 18 indexed citations
8.
Fendler, Annika, Lewis Au, Scott T.C. Shepherd, et al.. (2020). CAPTURE: Cancer and COVID-19 antiviral immune monitoring study. Clinical Cancer Research. 26(18).
9.
Matoori, Simon, Yee Liang Thian, Dow‐Mu Koh, et al.. (2017). Contrast-Enhanced CT Density Predicts Response to Sunitinib Therapy in Metastatic Renal Cell Carcinoma Patients. Translational Oncology. 10(4). 679–685. 9 indexed citations
10.
Giles, Rachel H., Toni K. Choueiri, Daniel Y.C. Heng, et al.. (2017). Recommendations for the Management of Rare Kidney Cancers. European Urology. 72(6). 974–983. 33 indexed citations
11.
Armstrong, Andrew J., Susan Halabi, Tim Eisen, et al.. (2016). Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. The Lancet Oncology. 17(3). 378–388. 311 indexed citations
12.
Wagstaff, John, Robert J. Jones, Robert D. Hawkins, et al.. (2015). Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry. Annals of Oncology. 27(1). 159–165. 33 indexed citations
13.
Pickering, Lisa, et al.. (2015). Is observation a valid strategy in metastatic renal cell carcinoma?. Current Opinion in Urology. 25(5). 390–394. 7 indexed citations
14.
Pickering, Lisa & James Larkin. (2015). Carbonic anhydrase IX in resected clear cell RCC. Nature Reviews Urology. 12(6). 309–310. 4 indexed citations
15.
Khattak, Muhammad A., Rosalie Fisher, Lisa Pickering, Martin Gore, & James Larkin. (2012). Endobronchial metastases from renal cell carcinoma: A late manifestation of the disease with an increasing incidence. British Journal of Urology. 110(10). 1407–1408. 1 indexed citations
16.
Fisher, Rosalie, Alexandra Pender, Kiruthikah Thillai, et al.. (2012). Observation as a treatment strategy for advanced renal cell carcinoma—a call for prospective validation. SHILAP Revista de lepidopterología. 2. 155–155. 18 indexed citations
17.
Fisher, Rosalie, Lisa Pickering, & James Larkin. (2011). New targeted therapies for renal cell carcinoma. Expert Opinion on Investigational Drugs. 20(7). 933–945. 2 indexed citations
18.
Larkin, James, Charles Swanton, & Lisa Pickering. (2011). Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action. Expert Review of Anticancer Therapy. 11(4). 639–649. 14 indexed citations
19.
Larkin, James, Tom Ferguson, Lisa Pickering, et al.. (2010). A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma. British Journal of Cancer. 103(8). 1149–1153. 33 indexed citations
20.
Pickering, Lisa, et al.. (2008). Sunitinib is superior to interferon α with respect to quality of life for patients with renal cell carcinoma. Nature Clinical Practice Oncology. 6(1). 6–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lionnel Geoffrois Breakdown of academic impact, for papers by Jinsoo Chung Breakdown of academic impact, for papers by Albiruni Ryan Abdul Razak Breakdown of academic impact, for papers by Teodoro Sava Breakdown of academic impact, for papers by Stephen B. Riggs Breakdown of academic impact, for papers by Nancy B. Davis Breakdown of academic impact, for papers by Enrique Gallardo Breakdown of academic impact, for papers by Philippe Barthélémy Breakdown of academic impact, for papers by Andrew Dean Breakdown of academic impact, for papers by Cristian Lolli
Rankless by CCL
2026